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Background: Nosocomial infection caused by methicillin resistant S. aureus (MRSA) presents with management 
difficulties in infected patients due to their resistance to a number of other frontline antibiotics and constitutes 
significant epidemiological problems. This study was undertaken to determine the prevalence of methicillin 
resistant S. aureus and antibiotic sensitivity pattern in clinical isolates in Kano. There is dearth of information on 
this subject in Kano.  
Method: One hundred and eighty five (185) S. aureus isolates from various clinical specimens obtained over a12-
month period in the Microbiology Department of Aminu Kano Teaching Hospital (AKTH) were subjected to 
methicillin susceptibility testing, while including susceptibility testing to other antibiotics by the disc diffusion 
methods. 
Result: Out of 185 S. aureus isolates tested, 53(28.6%) were found to be methicillin resistant. While 38(62%) 
isolates were obtained from in-patients, 15(28%) were from out-patients. Surgical wound infection had the 
highest prevalence of 32(60%) isolates. Antibiotics sensitivity results of methicillin susceptible staphylococcus 
aureus MSSA) and MRSA with the third generation cephalosporins and the quinilones were encouraging. All 
MRSA isolates were sensitive to vancomycin. 
Conclusion: A prevalence of 28.6% MRSA in this environment calls for urgent intervention strategies due to its 
possible rapid spread and therapeutic problem. 
 




S. aureus has long been established as an 
important pathogen in human disease. The 
emergence of MRSA strains found in increasing 
number of infections and often multi resistant in 
nature now pose serious therapeutic problems 
to clinicians.  
When penicillin was introduced in 1994, over 
95% of staphylococci isolates were susceptible to 
the drug. Today, the proportion has shrunk to 
10%. The resistance of S. aureus to various 
antibiotics and particularly to methicillin has  
 
become a global nosocomial concern. The 
introduction and the use of gentamycin in the 
late 1960’s and early 1970’s halted the 
development of MRSA. However, by the late 
1970’s gentamycin resistant MRSA had emerged 
(1). 
MRSA strains are usually resistant to several 
groups of broad spectrum antibiotics that are 
used on a large scale in the hospital. The 
mechanism of increased spreading under 





worldwide increase in the prevalence of MRSA 
in hospitals. (2) 
The most remarkable feature of S. aureus is its 
ability to acquire resistance to antibiotics. Many 
resistance genes are acquired by plasmid 
mediated gene transfer and some may be 
transferred to the chromosome as mobile genetic 
elements. Methicillin resistant strains usually 
possess more than four genes encoding different 
resistant mechanism (3). 
Classically, MRSA has been a nosocomial 
problem associated with long hospital stays, 
numerous or prolonged antibiotic courses, the 
presence of invasive devices and proximity to an 
already infected or colonised patient (4). 
 
Materials and methods 
Study Area: Aminu Kano Teaching Hospital is a 
500 bed tertiary hospital which also serves as a 
referral hospital for states surrounding Kano 
without such health facilities. It has emergency, 
general and specialist units for both pediatric 
and adult patients. 
Methods: One hundred and eighty five (185) 
consecutive isolates of S. aureus were obtained 
over a 12-month period from various clinical 
specimens in the Medical Microbiology 
Department of AKTH by standard procedures 
(5). They were subjected to methicillin 
susceptibility testing by using Mueller-Hinton 
agar supplemented with 4% NaCl. Culture 
plates were inoculated by dipping a sterile 
cotton swab into a suspension of the overnight 
growth of the organism prepared to the density 
of a McFarland no. 0.5 standard, expressed 
excess liquid from the swab and inoculated the 
surface of the agar by spread method. The 5µg 
methicillin discs (oxoid) were aseptically placed 
on the surface of the inoculated plates and 
incubated aerobically at 35oC for 24hrs. The 
isolates were also similarly inoculated into the 
surfaces of plain Mueller-Hinton agar plates and 
Ofloxacin (10µg), Ceftazidim (30µg), Ceftriaxone 
(30µg). Ciprofloxacin (5µg), Vancomycin (30µg) 
discs (Abbot Laboratories) were placed and also 
incubate at 35oC for 24hrs. 
The zones of inhibition were measured and 
compared with National committee for clinical 
laboratory standards (NCCL) guidelines (6). The 
isolates that were resistant to the methicillin 
(<14mm) were termed methicillin resistant S. 
aureus (MRSA) while those with zone of 
inhibition as (≥ 14mm) were termed susceptible. 
Antibiotic susceptibility tests were carried out 
by modified Kirby-Bauer method (7). 
 
Results: Out of 185 isolates of S. aureus testes 
53(28.6%) were found to be methicillin resistant. 
Of the 53 MRSA isolates 38(62%) were obtained 
from In-patients, 15(28%) were from out-
patients. 
The percentage distribution of MRSA for each 
service unit is show in Tabe 1. Surgery 
department had the highest prevalence of 40% 
while General out-patient department (GOPD), 
Accident and emergency, Pediatrics, Special care 
baby unit and medical words had 20%, 4%, 3%, 
6% and 17% respectively. 
Table 2 shows the percentage distribution of 





specimens. Surgical wound infection showed 
the highest record with 60% while Ear swab, 
Urine from urinary tract infection, Skin swab 
and swab from Eye infections recorded 18%, 
11%, 7, and 4% respectively. 
Table 3 shows the antibiotic susceptibility of the 
MSSA and MRSA isolates to methicillin and six 
other antibiotics. While 71.4% of all the isolates 
were sensitive to methicillin, 28.6% were 
resistant. The antibiotic sensitivity profile of 
MRSA to various antibiotics was as follows, 
Ciprofloxacin (64%), Ofloxacin (90%), 
Amoxycillin/clavulanic acid (31.7%), 
Ceftriaxone (75%), Gentamicin (18%) and 
Ceftazidim (79%). The percentage sensitive for 
the MSSA were recorded as follows; Methicillin 
(100%), Ciprofloxacin (68%), Ofloxacin (93%), 
Amoxycillin/clavulanic acid (62%), Ceftriaxone 
(90%), Gentamicin (75%) while Ceftazidime was 
(92%). 
All the isolates were sensitive to Vancomycin.  
 
TABLE 1: DISTRIBUTION OF MRSA BY SERVICE  
                           UNIT AT AKTH, KANO 
SERVICE No. POSITIVE (%) 
GOPD 11 (20) 
MEDICINE 9 (17)  
SURGERY 21 (40) 
PAEDIATRICS 7 (13) 
SPECIAL CARE BABY UNIT 3 (6) 
ACCIDENT & EMERGENCY 2(4) 
TOTAL 53 (100) 
 
 
TABLE 2: DISTRIBUTION OF MRSA ISOLATES 
 BY SOURCE OF SPECIMEN AT AKTH, KANO 
SITE OF INFECTION No. POSITIVE (%) 
SURGICAL WOUNDS 32(60) 
EAR SWAB 10 (18)  
URINE 6 (11) 
SKIN 3 (77) 
EYE SWAB 2 (4) 




TABLE 3: ANTIBIOTICS SUSCEPTIBILITY PATTERN OF MSSA AND MSRA AT AKTH KANO 
 
No. OF ISOLATES (% SENSITIVE 
S. aureus Meth CIP OFL AMC CRO CN CAZ 



























10  (18) 
 
42 (79) 
Meth – Methicillin 
CIP – Ciprofloxacin  
OFL – Ofloxacin 
AMC – Amoxycillin/clavulanic acid 
CRO – Ceftriaxone  
CN – Gentamyin  











Although it was not possible to carry out a 
polymerase chain reaction (PCR) to detect 
mecA gene which is regarded as the gold  
standard for determining methicillin 
resistance, sensitivity to or not with 5µg 
methicillin discs (oxoid) were used. This 
was the same method adopted by the other 
studies used for comparison with this 
present report. In this study, a prevalence 
rate of 28.6% MRSA was recorded. This is 
lower than the study in Jos (8) and Ilorin (9), 
Nigeria which had prevalence rates of 43% 
and 34.7% respectively. 
In another study (10) comprising eight large 
hospitals in Africa and Malta, a prevalence 
rate of 16% was observed. MRSA was 
relatively high in Nigeria, Kenya and 
Cameroon (21-30%), and below 10% in 
Tunisia Malta and Algeria.  
In Europe MRSA prevalence varied almost a 
100 fold in a study, (11) form <1% in 
northern Europe to >40% in southern and 
Western Europe. 
In the United States (12) the proportion of 
MRSA was rapidly increased from below 
5% in the 1980’s to 29% in 1991. 
From the foregoing, it is clear the MRSA has 
become a global nosocomial pathogen with 
attendant therapeutic problems. 
The low prevalence of 6% MRSA in the 
special baby care unit (SBCU) highlights the 
awareness interventions of the staff there to 
prevent nosocomial infection while the high 
prevalence of 40% in the surgical world 
would be attributed to lack of adequate  
 
precaution and very limited infection 
control applications. 
The antibiotic susceptibility results of MRSA 
in this study to third generation 
cephalosporins and the quinolones was 
quite encouraging and compared favorably 
well with the study from Ilorin (9). 
However, the study (8) at Jos showed a low 
percentage sensitivity of MRSA to the 
cephalosporins but good results with the 
quinolones. 
This result will be of local clinical relevance 
in the treatment of MRSA in this 
environment especially when vancomicin is 
not commonly available in this area. 
There should be an effective infection 
control committee to coordinate 
implementation of its policies especially 
regular hand washing and strict ward 
antisepsis to reduce nosocomial infections.  
Although vancomycin resistant MRSA is not 
yet common in this part of the world, the 
rate of spread of this pathogen and its 
unique ability to acquire and transfer 
antibiotic resistance calls for urgent and well 
coordinated surveillance programme to 
combat this situation. 
There should also be strict antibiotic 
prescription policies enforced by the 
appropriate authorities to contain the abuse 
of antibiotics and reduce acquisition of 
resistance by pathogens. Educational 
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